FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling application for Micardis HCT (telmisartan/hydrochlorothiazide).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MICARDIS HCT (Telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for MICARDIS HCT (TELMISARTAN AND HYDROCHLOROTHIAZIDE)